The global rise in antimicrobial resistance (AMR) continues to be one of the leading causes of human death.1–3 Bacterial AMR was associated with approximately 5 million deaths in 2019 and 2021.1,2 Health inequalities disproportionately increase the risk of AMR, often seen in low- and middle-income countries,4 but also starkly evident within the UK.
Also of interest
-
RCPath Recommendations for verification validation of sample-sets assays SARS-CoV-2
This guidance is produced to assist NHS and research laboratories to evaluate immunoassays for clinical use and help to meet ISO accreditation standards for clinical use. Version 2 – updated 26 May 2020.
-
Preventing allergic disease: Why early action matters for patients and families
Dr Michael Perkin reports on preventing allergy.